Bold new approaches are needed to propel biomedical discoveries from benchtop to bedside. Biomedical science needs to form strategic collaborations, unlock new sources of capital and adopt new research models to accelerate the translation of basic research to new medicines that address unmet medical needs.
This session will explore novel approaches taken by leading research institutions to transform research breakthroughs into outstanding patient care. From self-financing of start-up companies to commercialization alliances with top pharmaceutical companies and public/private partnerships, this panel will describe the new gold standard for how academic, industry and government partners can confront serious diseases.
Session ID: 21913